Medtronic breaks ground on western China Innovation Center
Medtronic (NYSE:MDT) said today it has begun work on an Innovation Center in Chengdu, China, slated to open in 2020. The new Chengdu Innovation Center is being built at the Singapore-Sichuan Hi-Tech Innovation Park in the Sichuan Province and aims to provide clinical training and research platforms for medical workers in the region and neighboring regions. “Medtronic understands the critical role that rural physicians play in driving the healthcare availability and transformation. As such, we hope to support the growth and development of medical workers in China’s vast central and western regions, help them better understand, grasp and capitalize the frontier technologies, enhance their clinical skills to benefit more patients, and move forward together toward the Healthy China goal,” Medtronic CEO Omar Ishrak said in a prepared statement. Medtronic said that despite improved clinical training investments, training in China’s western regions “remains insufficient” and has created an average 10-year gap between the maturation period of Chinese physicians and those in developed countries. “Chengdu is actively fostering innovation within the biopharmaceutical industry, and it’s particularly important to build an open and pragmatic innovation environment. We hope that more international leading platforms, like the Medtronic Innovation Center, can inspire innovation and become a driving force in helping us explore loca...
Endovascular repair of ruptured abdominal aortic aneurysm was linked to reduced mortality at 3 years, improved early quality of life, and reduced costs compared with open surgery in the IMPROVE trial.Medscape Medical News
We would like to tell you about the December issue of the Journal of Vascular Surgery and some of the key articles. The first paper, by Chandra and co-authors from Stanford, entitled “Management and outcomes of symptomatic abdominal aortic aneurysms during the past 20 years,” compares symptomatic patients with abdominal aortic aneurysm (AAA), defined as those who had new onset abdominal pain or aneurysm tenderness with no rupture found by computed tomography scan or in the operating room. In these patients, the repair of AAA was primarily open from 1995 to 2004 and evolved to primarily endovascular repair ...
The observed reduction of mortality risk from abdominal aortic aneurysm, peripheral arterial disease, and hypertension has never been seen before in the population screening literature and can be linked primarily to initiation of pharmacological therapy. Health policy makers should consider implementing combined screening whether no screening or isolated abdominal aortic aneurysm screening is currently offered.
The aim was to assess the survival of patients who had been turned down for repair of an abdominal aortic aneurysm (AAA) and to examine the factors influencing this.
I support and appreciate the recent examination of gender differences in the treatment of abdominal aortic aneurysm (AAA) recently addressed by Deery et al in this publication.1 The authors make a compelling case that women are likely to be underserved where endovascular aneurysm repair (EVAR) is concerned and, as a result, are at higher risk for 30-day death and major complications. Other studies have concurred with the higher rate of female comp lications.2-5
We appreciate your comments about our work and are eagerly anticipating the first publications from the TriVascular Evaluation of Females Who Are Underrepresented Candidates for Abdominal Aortic Aneurysm Repair (LUCY) study. We agree that the outcomes in women with abdominal aortic aneurysms have repeatedly been shown to be suboptimal, and these data can no longer be overlooked. As Dr Ash described, women have been poorly represented in all major randomized, controlled trials and are likely also to be under-represented in retrospective series, including ours, of outcomes in patients undergoing endovascular aneurysm repair ...
Loss of muscle mass has been associated with poor survival in several surgical patient populations, including those with an abdominal aortic aneurysm (AAA). We wanted to replicate these findings and assesse the association between psoas muscle area (PMA) and survival in patients with an asymptomatic AAA.
The American College of Cardiology and the American Heart Association certainly grabbed the attention of us busy primary care physicians with the recent release of their updated blood pressure guidelines. These organizations had piqued interest by declaring the release date and labeling it as “highly anticipated.” I pooh-poohed all that drama, but upon reading through the 114-page executive summary PDF with 21 authors and almost a thousand references, I have to say, I am duly impressed. The definition of the diagnosis of high blood pressure and the decision-making process surrounding treatment have traditionall...
ConclusionUnlike other studies which showed an increase in PCSK9 after the onset of stress, our study detected a fall in PCSK9 following acute surgical stress. The observed difference is likely due to the earlier timing of PCSK9 measurement in our study. Further studies involving serial poststress measurements for several days are needed to determine whether PCSK9 behaves as an acute‐phase reactant, whether it displays a biphasic response to acute stress, and whether changes in circulating PCSK9 are responsible for lipoprotein changes observed after surgical stress. (Clinical Trial Registration: ClinicalTrials.gov study ID NCT00493389)
Dr Lowenfels comments on a study that investigated whether metformin could significantly slow the growth rate of this very common disease.Medscape General Surgery
More News: Abdominal Aortic Aneurysm | Academia | Aortic Aneurysm | Cardiology | Cardiovascular | Cardiovascular & Thoracic Surgery | China Health | Environmental Health | Gastroenterology | Heart | Intensive Care | Internal Medicine | Minimally Invasive Surgery | Respiratory Medicine | Rural Health | Singapore Health | Training | Universities & Medical Training